生命科学资讯

Single-Cell Genome Sequencing Market Is Going to Boom |• 10x Genomics • Illumina - openPR.com

UK-US biotech investor Epidarex raises $145M for fourth fund

The Analyst Verdict: Illumina In The Eyes Of 15 Experts - Benzinga

IRA drug pricing petitions pile up at the Supreme Court

Clinical Ambitions: 10x Expands Beyond Research with Trio of Collaborations - GEN - Genetic Engineering and Biotechnology News

Ex-CytoDyn CEO sentenced to prison, must pay $5.3M restitution as former CRO leader wins new trial

European investment firm Gimv calls it quits on new life science financing

New rules, higher stakes: Biopharma plays the long game in 2026

China’s edge in early-stage drugmaking ‘likely to persist,’ Pitchbook says

Ex-CytoDyn CEO sentenced to 30 months for pump-and-dump scheme

Med-tech gainers and losers for Jan. 19-23, 2026

Catalent plans to close Belgium cell therapy site

Financings for Jan. 26, 2026

In the clinic for Jan. 26, 2026

Other news to note for Jan. 26, 2026

Regulatory actions for Jan. 26, 2026

Sarepta, battling slowing sales, claims Duchenne gene therapy’s impact grows with time

Sarepta touts three-year Duchenne gene therapy data after patient deaths

Feds charge former Zynex execs in massive medtech billing fraud case

Guardant Health gets FDA nod to expand use of blood test for colon cancer